2-naphthol has been researched along with Experimental Mammary Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, MH; Jeong, SK; Jo, WS; Kang, YR; Kim, JS; Lee, CG; Oh, SJ | 1 |
| Choi, YJ; Heo, K; Jeong, MH; Park, HS; Yang, KM | 1 |
| Beriel, H; Berlion, M; Fillion, H; Laharotte, C; Riondel, J; Rougny, A | 1 |
3 other study(ies) available for 2-naphthol and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
The resveratrol analogue, HS‑1793, enhances the effects of radiation therapy through the induction of anti‑tumor immunity in mammary tumor growth.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoradiotherapy; Concanavalin A; Female; Interleukin-10; Mammary Neoplasms, Experimental; Mice; Naphthols; Radiation-Sensitizing Agents; Resorcinols; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Treatment Outcome; Xenograft Model Antitumor Assays | 2020 |
The resveratrol analog HS-1793 enhances radiosensitivity of mouse-derived breast cancer cells under hypoxic conditions.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Movement; Cell Survival; Enzyme-Linked Immunosorbent Assay; Female; Hypoxia; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Microscopy, Fluorescence; Naphthols; Neoplastic Stem Cells; Neovascularization, Pathologic; Radiation Tolerance; Radiation-Sensitizing Agents; Real-Time Polymerase Chain Reaction; Resorcinols; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2016 |
[In vivo antitumor activity of 5-hydroxy 3,4-dihydro naphthalene 1,8-carbolactone and its derivatives].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Mammary Neoplasms, Experimental; Mice; Naphthols; Tumor Cells, Cultured | 1988 |